Exploiting translation inhibition: antitumor efficacy of SVC112 in preclinical models of colorectal cancer

被引：0
|
作者：
Robertson, Kelli M. [1 ]
Gustafson, Annika L. [1 ]
Tentler, John J. [1 ]
Bagby, Stacey M. [1 ]
Anna, Capasso [1 ]
Klauck, Peter J. [1 ]
Pitts, Todd M. [1 ]
Kim, Jihye [1 ]
Tan, Aik Choon [1 ]
Su, Tin Tin [2 ]
Eckhardt, S. Gail [1 ]
机构：
[1] Univ Colorado, Sch Med, Denver, CO USA
[2] Univ Colorado, Denver, CO 80202 USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期
关键词：
D O I：
10.1158/1535-7163.TARG-17-B051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B051
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer
    Enriquez-Navas, Pedro M.
    Kam, Yoonseok
    Das, Tuhin
    Hassan, Sabrina
    Silva, Ariosto
    Foroutan, Parastou
    Ruiz, Epifanio
    Martinez, Gary
    Minton, Susan
    Gillies, Robert J.
    Gatenby, Robert A.
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (327)
  • [42] Exploiting GLAAD molecules to drive an antitumor immune response in a colorectal cancer mouse model
    Adesokan, Yemi
    Spalinger, Marianne Rebecca
    Wyss, Romain
    Miao, Yong
    Scharl, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [43] Sustained inhibition of deacetylases is required for the antitumor activity of the histone deactylase inhibitors panobinostat and vorinostat in models of colorectal cancer
    Wilson, Peter M.
    LaBonte, Melissa J.
    Martin, Shelby C.
    Kuwahara, Stephanie T.
    El-Khoueiry, Anthony
    Lenz, Heinz-Josef
    Ladner, Robert D.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (04) : 845 - 857
  • [44] Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer
    Matsumoto, M
    Takeda, Y
    Maki, H
    Hojo, K
    Wada, T
    Nishitani, Y
    Maekawa, R
    Yoshioka, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (01): : 51 - 58
  • [45] An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer
    Jacob, Joan
    Francisco, Liezl E.
    Chatterjee, Treena
    Liang, Zhengdong
    Subramanian, Shraddha
    Liu, Qingyun J.
    Rowe, Julie H.
    Carmon, Kendra S.
    BRITISH JOURNAL OF CANCER, 2023, 128 (08) : 1592 - 1602
  • [46] Sustained inhibition of deacetylases is required for the antitumor activity of the histone deactylase inhibitors panobinostat and vorinostat in models of colorectal cancer
    Peter M. Wilson
    Melissa J. LaBonte
    Shelby C. Martin
    Stephanie T. Kuwahara
    Anthony El-Khoueiry
    Heinz-Josef Lenz
    Robert D. Ladner
    Investigational New Drugs, 2013, 31 : 845 - 857
  • [47] Characterization of radiosensitization by kinase inhibition in preclinical pancreatic cancer models
    Pangerl, Julia
    Spiess, Lukas
    Hoffmueller, Patricia
    Crocione, Alessia
    Kessler, Christopher
    Wiechmann, Svenja
    Schneider, Guenter
    Schmid, Roland M.
    Kuster, Bernhard
    Schilling, Daniela
    Combs, Stephanie E.
    Dobiasch, Sophie
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5429 - S5431
  • [48] Entinostat enhances the efficacy of olaparib in preclinical models of ovarian cancer
    Gupta, Vijayalaxmi G.
    Fernandez, Yoskaly Lazo
    Roby, Katherine
    Pathak, Harsh
    Hirst, Jeff
    Wilson, Andrew J.
    Godwin, Andrew
    Khabele, Dineo
    CANCER RESEARCH, 2019, 79 (13)
  • [49] Antitumor Efficacy of CC Motif Chemokine Ligand 19 in Colorectal Cancer
    Jun Lu
    Jingkun Zhao
    Hao Feng
    Puxiongzhi Wang
    Zhuo Zhang
    Yaping Zong
    Junjun Ma
    Minhua Zheng
    Aiguo Lu
    Digestive Diseases and Sciences, 2014, 59 : 2153 - 2162
  • [50] Hyaluronidase improves the efficacy of nab-paclitaxel after prolonged angiogenesis inhibition in preclinical models for esophagogastric cancer
    Liu, Dajia
    Guo, Lihui
    Waasdorp, Cynthia
    Meijer, Sybren L.
    Bootsma, Sanne
    Oyarce, Cesar
    Bijlsma, Maarten F.
    van Laarhoven, Hanneke W. M.
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 178
12345